Other than as set forth below, during the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) promulgated under the Exchange Act) adopted or terminated any “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as each term is defined in Item 408 of Regulation S-K).

​

On June 3, 2026, Alissa Fitzgerald, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the potential sale of up to 14,869 shares of our Common Stock, including shares obtained from the potential exercise of vested stock options, depending on the market prices of the securities. The plan is scheduled to terminate on June 1, 2027, subject to earlier termination upon the sale of all securities subject to the plan, or as otherwise provided in the plan.

​

On June 4, 2026, Jeffrey Bertelsen, our Chief Financial Officer, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the potential sale of up to 450,000 shares of our Common Stock obtained from the potential exercise of vested stock options, depending on the market prices of the securities. The plan is scheduled to terminate on December 31, 2027, subject to earlier termination upon the sale of all securities subject to the plan, or as otherwise provided in the plan.

​

On June 10, 2026, Subodh Kulkarni, our Chief Executive Officer and a member of our board of directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the potential sale of up to 1,120,000 shares of our Common Stock obtained from the potential exercise of vested stock options, depending on the market prices of the securities. The plan is scheduled to terminate on December 31, 2027, subject to earlier termination upon the sale of all securities subject to the plan, or as otherwise provided in the plan.

​

On June 15, 2026, Michael Clifton, a member of our board of directors, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act. The plan provides for the potential sale of up to 300,000 shares of our Common Stock, depending on the market prices of the securities. The plan is scheduled to terminate on September 14, 2027, subject to earlier termination upon the sale of all securities subject to the plan, or as otherwise provided in the plan.